Tilvestamab Fab bound to the anti-Fab nanobody
External Resource: Annotation
SAbDab Antibody Annotation SAbDab Database Homepage
| Chain | Chain Class | Chain Subclass | Chain Type | Antigen Name(s) | Provenance Source |
|---|---|---|---|---|---|
| C [auth H] | Heavy Chain | IGHV3 | - | - | SAbDab (2026-03-13) |
| B [auth K] | Heavy Chain | IGHV1 | - | - | SAbDab (2026-03-13) |
| A [auth L] | Light Chain | IGKV1 | Kappa | - | SAbDab (2026-03-13) |
Thera-SAbDab Antibody Annotation Thera-SAbDab Database Homepage
| Chain | Name | Target | Provenance Source |
|---|---|---|---|
| C [auth H] | Tilvestamab | AXL/UFO | Therapeutic SAbDab (2026-03-13) |
| A [auth L] | Tilvestamab | AXL/UFO | Therapeutic SAbDab (2026-03-13) |














